Charles Schwab Investment Management Inc Clovis Oncology, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.05 - $2.85 $541,249 - $1.47 Million	-515,476 Reduced 89.89%	58,000 $70,000
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.96 $223,502 - $1.05 Million	-354,766 Reduced 38.22%	573,476 $1.03 Million
Q1 2022 May 13, 2022	BUY	$1.43 - $3.14 $109,566 - $240,586	76,620 Added 9.0%	928,242 $1.88 Million
Q4 2021 Feb 11, 2022	BUY	$2.7 - $4.76 $284,993 - $502,432	105,553 Added 14.15%	851,622 $2.31 Million
Q3 2021 Nov 16, 2021	BUY	$4.06 - $5.8 $173,865 - $248,379	42,824 Added 6.09%	746,069 $3.33 Million
Q2 2021 Aug 16, 2021	BUY	$5.02 - $7.05 $195,333 - $274,322	38,911 Added 5.86%	703,245 $4.08 Million
Q1 2021 May 17, 2021	BUY	$4.81 - $10.34 $435,473 - $936,131	90,535 Added 15.78%	664,334 $4.66 Million
Q4 2020 Feb 16, 2021	SELL	$4.13 - $6.41 $1,598 - $2,480	-387 Reduced 0.07%	573,799 $2.76 Million
Q3 2020 Nov 13, 2020	BUY	$4.82 - $7.72 $93,671 - $150,030	19,434 Added 3.5%	574,186 $3.35 Million
Q2 2020 Aug 14, 2020	BUY	$5.69 - $9.69 $830,722 - $1.41 Million	145,997 Added 35.72%	554,752 $3.75 Million
Q1 2020 May 15, 2020	BUY	$3.77 - $11.0 $347,673 - $1.01 Million	92,221 Added 29.13%	408,755 $2.6 Million
Q4 2019 Feb 07, 2020	BUY	$3.0 - $16.43 $18,249 - $99,943	6,083 Added 1.96%	316,534 $3.3 Million
Q3 2019 Nov 08, 2019	BUY	$3.93 - $15.35 $35,393 - $138,242	9,006 Added 2.99%	310,451 $1.22 Million
Q2 2019 Aug 09, 2019	BUY	$12.81 - $25.67 $130,879 - $262,270	10,217 Added 3.51%	301,445 $4.48 Million
Q1 2019 May 14, 2019	BUY	$17.66 - $30.28 $240,741 - $412,776	13,632 Added 4.91%	291,228 $7.23 Million
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $23,632 - $66,385	-2,032 Reduced 0.73%	277,596 $4.99 Million
Q3 2018 Nov 13, 2018	BUY	$29.37 - $49.48 $431,797 - $727,454	14,702 Added 5.55%	279,628 $8.21 Million
Q2 2018 Aug 08, 2018	BUY	$42.06 - $62.4 $1.48 Million - $2.2 Million	35,192 Added 15.32%	264,926 $12 Million
Q1 2018 May 07, 2018	BUY	$50.12 - $67.72 $441,557 - $596,613	8,810 Added 3.99%	229,734 $12.1 Million
Q4 2017 Jan 17, 2018	BUY	$57.69 - $84.58 $636,320 - $932,917	11,030 Added 5.26%	220,924 $15 Million
Q3 2017 Nov 13, 2017	BUY	$67.17 - $84.81 $14.1 Million - $17.8 Million	209,894	209,894 $17.3 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account